Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year
Certara wins Great Place to Work Certification, with 85% of employees praising workplace culture, innovation,…
CertaraJune 13, 2025
A Quantitative Systems Pharmacology Model to Investigate the Crucial Role of Epithelial Damage in the Pathogenesis of Inflammatory Bowel Disease
In inflammatory bowel disease (IBD) patients, there is an imbalance between pro- and anti-inflammatory cytokines.…
Danielle PillsburyJune 13, 2025
Faster Mapping from Source Data to Target SDTM
Explore a collaborative, web-based solution for generating CDISC dataset mapping specs from standards and studies.
CertaraJune 12, 2025
Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance
With the release of the draft ICH M15 guidance, MIDD is no longer optional -…
CertaraJune 11, 2025
What are the most common in vitro drug-drug interaction study gaps?
Certara drug interaction science experts share data and experimental design gaps commonly found in in…
CertaraJune 9, 2025
Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer
The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…
CertaraJune 8, 2025
